Trademark: 87649765
Word
ENKLUMA
Status
Dead
Status Code
606
Status Date
Monday, February 4, 2019
Serial Number
87649765
Mark Type
4000
Filing Date
Wednesday, October 18, 2017
Published for Opposition
Tuesday, May 8, 2018
Abandoned Date
Monday, February 4, 2019

Trademark Owner History
H. Lundbeck A-S - Owner At Publication

Classifications
5 Vaccines; pharmaceutical preparations and substances for the prevention and treatment of disorders and diseases in, generated by or acting on the central nervous system; pharmaceutical preparations and substances acting on the central nervous system; central nervous system stimulants; pharmaceutical preparations and substances for the prevention and treatment of psychiatric and neurological disorders and diseases; pharmaceutical preparations and substances for the prevention and treatment of dementia, Alzheimer's disorder and disease, dizziness, seizures, stroke, depression, cognitive impairment, cognitive disorders and diseases, mood disorders, psychosis, anxiety, apathy, epilepsy; pharmaceutical preparations and substances for the prevention and treatment of Lennox-Gastaut syndrome (LGS), sclerosis, porphyria, Huntington's disorder and disease, insomnia, Parkinson's disorder and disease, falls, movement disorders and diseases, tremor, schizophrenia, bipolar disorder and disease, mania, ADHD, PTSD, agitation, aggression, autism, melancholy, OCD, Tourette's syndrome, progressive supranuclear palsy (PSP), restlessness, akathisia, fatigue, somnolence, nausea, cancer, migraine, pain, alcoholism and dependency; diagnostic agents, reagents, preparations and substances for medical purposes
10 Medical apparatus and instruments for use in diagnosing and monitoring vital signs of patients with psychiatric and neurological disorders and diseases, dementia, Alzheimer's disorder and disease, dizziness, seizures, stroke, depression, cognitive impairment, cognitive disorders and diseases, mood disorders, psychosis, anxiety, apathy, epilepsy, Lennox-Gastaut syndrome (LGS), sclerosis, porphyria, Huntington's disorder and disease, insomnia, Parkinson's disorder and disease, falls, movement disorders and diseases, tremor, schizophrenia, bipolar disorder and disease, mania, ADHD, PTSD, agitation, aggression, autism, melancholy, OCD, Tourette's syndrome, progressive supranuclear palsy (PSP), restlessness, akathisia, fatigue, somnolence, nausea, cancer, migraine, pain, alcoholism and dependency; injection devices for pharmaceuticals, syringes and needles for injections and medical purposes; integrated medical systems, namely, medical diagnostic imaging apparatus and software sold as a unit therewith for managing, measuring, monitoring, assessing, controlling, collecting, storing and examining patient and client data and information captured by the medical system in web-based physical, psychological and neurological examinations conducted at a distance and at a clinic; medical apparatus and units for dosage, measuring and monitoring, namely, drug delivery devices and systems

Trademark Events
Feb 4, 2019
Abandonment Notice E-Mailed - No Use Statement Filed
Feb 4, 2019
Abandonment - No Use Statement Filed
Jul 3, 2018
Noa E-Mailed - Sou Required From Applicant
May 8, 2018
Official Gazette Publication Confirmation E-Mailed
May 8, 2018
Published For Opposition
Apr 18, 2018
Notification Of Notice Of Publication E-Mailed
Mar 29, 2018
Assigned To Lie
Mar 21, 2018
Approved For Pub - Principal Register
Mar 21, 2018
Examiner's Amendment Entered
Mar 21, 2018
Notification Of Examiners Amendment E-Mailed
Mar 21, 2018
Examiners Amendment E-Mailed
Mar 21, 2018
Examiners Amendment -Written
Jan 27, 2018
Notification Of Non-Final Action E-Mailed
Jan 27, 2018
Non-Final Action E-Mailed
Jan 27, 2018
Non-Final Action Written
Jan 25, 2018
Assigned To Examiner
Oct 27, 2017
New Application Office Supplied Data Entered In Tram
Oct 21, 2017
New Application Entered In Tram

Trademark Alertz updated from USPTO on 2030-01-24